Skip to content
Home/Companies/MedTech/Binding Site

Binding Site

MedTech·United Kingdom·Exited 2023·Held 12yr
Entry
2011
Hold
12yr
Exit
2023

Who owns Binding Site?

Binding Site is a British MedTech company, now owned by Thermo Fisher Scientific, which acquired it in 2023 from Nordic Capital.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital Fund VII · 2008 · Buyout

Key facts

HQUnited Kingdom
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Thermo Fisher Scientific
Exit Year
2023

More from Nordic Capital Fund VII

Other portfolio companies in the same fund.

Anticimex
Anticimex
Exited 2006
Business ServicesSweden
to Ratos
Ahlsell
Exited 2016
ConstructionSweden· 2012
Bladt Industries A/S
Active
ConstructionDenmark· 2012
Europris
Exited 2015
ConsumerNorway· 2012
Itiviti
Exited 2021
FintechSweden· 2012
to Broadridge Financial Solutions
Resurs Group
Exited 2016
FintechSweden· 2012

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Binding Site?

Binding Site is now owned by Thermo Fisher Scientific, which acquired it in 2023 from Nordic Capital.

When did Thermo Fisher Scientific acquire Binding Site?

Thermo Fisher Scientific acquired Binding Site in 2023, buying from Nordic Capital.

Who did Binding Site sell to?

Nordic Capital sold Binding Site to Thermo Fisher Scientific in 2023 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue